Last reviewed · How we verify

NCT03660007

Incidence of Pulmonary and Venous Thromboembolism in IVF Pregnancies After Fresh and Frozen Embryo Transfer

Completed Last updated 6 September 2018
What this trial tests

trial testing Fresh or frozen embryo transfer IVF in Assisted Reproductive Techniques in 902,891 participants. Completed in 31 December 2014.

Timeline
1 January 1992
Primary endpoint
31 December 2012
31 December 2014

Quick facts

Lead sponsorKarolinska Institutet
StatusCompleted
Study typeOBSERVATIONAL
Enrollment902,891
Start date1 January 1992
Primary completion31 December 2012
Estimated completion31 December 2014

Drugs / interventions tested

Conditions studied

Sponsor

Karolinska Institutet

Who can join

Adults 15 to 50, female only, with Assisted Reproductive Techniques or Pregnancy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In vitro fertilization (IVF) is associated with an increased risk of venous thromboembolism and in particular pulmonary embolism during the first trimester. It is not known whether this increased risk of pulmonary embolism is present both after fresh and frozen embryo transfer. Objective: To assess whether the risk of pulmonary embolism and venous thromboembolism during the first trimester of IVF pregnancies is associated with both fresh and frozen embryo transfer. A population-based cohort study with linked data from nationwide registries on women in Sweden giving birth to their first child 1992-2012

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Karolinska Institutet trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03660007.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing